Preeclampsia Task Force


The overall goals and objectives of the CMQCC Preclampsia Task Force are to: 

  • Define standard terminology of hypertension in pregnancy utilizing NIH, AHA, and ACOG classification guidelines
  • Conduct a literature review and develop best practice guidelines and recommendations based on key issues identified through the PAMR analysis of preeclampsia cases
  • Develop a preeclampsia toolkit to educate providers across the care continuum (prenatal through postpartum), including different practice settings, i.e. outpatient clinics and the emergency department, with best practice strategies to improve the quality of care and reduce morbidity and mortality
  • Design process and outcome measures to evaluate and analyze the impact of a standardized approach to preeclampsia recognition, diagnosis and management.

Preeclampsia is one of the leading causes of Maternal Mortality and one with a high level of preventability.  Quality improvement opportunities were identified through the CA-PAMR case reviews that naturally lead to teaching points and items for a toolkit.   Issues that the task force will focus on will be: 1) missed and under diagnosis of preeclampsia; 2) the role of triggers; 3) under-use and misuse of hypertensive medications; and 4) special issues for the Emergency Department.  Further topics will be identified during task force meetings and through further PAMR analyses.



Preeclampsia Task Force Committee Members

  • Thomas Archer MD, UC San Diego Medical Center, Director, OB Anesthesia(San Diego)
  • Ocean Berg RN, MSN, CNS, Public Health Nurse(San Francisco)
  • Claire Brindis DrPH, Director, Professor of Pediatrics and Health Policy(San Francisco)
  • Valerie Cape CMQCC, Program Manager(Stanford)
  • Brenda Chagolla RNC, MSN, CNS(Davis)
  • Holly Champagne MSN, RNC, CNS, Kaiser (Roseville)
  • Meredith Drews Preeclampsia Foundation
  • Maurice Druzin MD, Stanford University/Lucile Packard Children's Hospital, Chief, Division of Maternal-Fetal Medicine(Palo Alto)
  • Racine Edwards-Silva MD, FACOG, Olive View-UCLA Medical Center, Assistant Professor(Sylmar)
  • Kristi Gabel RNC, MN, CNS, Perinatal CNS(Roseville)
  • Dana Hughes DrPH, Professor of Health Policy(San Francisco)
  • Thomas Kelly MD, UCSD School of Medicine, Director, Clinical Professor of Reproductive Medicine(San Diego)
  • Sarah Kilpatrick MD, PhD, Cedars Sinai, Chair Dept of Obstetrics and Gynecology, Visiting Professor of OB/GYN, David Geffen School of Medicine, UCLA(Los Angeles)
  • Richard H. Lee MD, Keck School of Medicine, USC, Assistant Professor(Los Angeles)
  • Audrey Lyndon PhD, RNC, CNS-BC, FAAN, UCSF School of Nursing, Associate Professor & Director(San Francisco)
  • Elliott Main MD, California Pacific Med Ctr/CMQCC, Chairman and Chief of Obstetrics(San Francisco)
  • Mark Meyer MD, FAAEM, Kaiser San Diego Medical Center
  • Allana Moore Program Assistant(Stanford)
  • Christine Morton PhD, CMQCC, Research Sociologist(Stanford)
  • Michael Orosco MD, Kaiser San Diego Medical Center(San Diego)
  • Nancy Peterson RNC, PNNP, MSN, IBCLC, Mid-Coastal California Perinatal Programs, MCCPOP(Palo Alto)
  • Larry Shields MD, Marian Perinatal Center, Perinatologist(Santa Maria)
  • Eleni Tsigas Preeclampsia Foundation, Executive Director
  • Linda V. Walsh PhD, CNM, FACNM, Associate Professor(San Francisco)
  • Mark Zakowski MD, Cedars-Sinai Medical Center(Los Angeles)